Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
270 results found
2017 ∙ ACIP
October 2017 - meeting minutes
Agenda & Minutes Americas United States of America Adolescents Adults vaccine safety Herpes zoster Influenza Mumps Human papillomavirus (HPV) Japanese encephalitis Pneumococcal disease
Download:
2017 ∙ Haute Autorité de Santé
Meeting minutes of the French NITAG - 19 December 2017
Agenda & Minutes Europe France Pneumococcal disease
Download:
2017 ∙ Haute Autorité de Santé
Minutes of the CTV meeting - December 19th 2017
Agenda & Minutes Europe France Pneumococcal disease
Download:
2017 ∙ Haute Autorité de Santé
Minutes of the CTV meeting - November 21st 2017
Agenda & Minutes Europe France Pneumococcal disease Influenza Diphtheria Tetanus Pertussis Poliomyelitis
Download:
2017 ∙ WHO AFRO
Recommendation to replace PCV-10 by PCV-13 in routine immunization of children under the age of 12
Recommendation Africa Zambia Pneumococcal disease
Download:
2017 ∙ IVAC
The Evidence Base for Pneumococcal Conjugate Vaccines (PCVs)
Pneumococcal disease
Download:
2016 ∙ Saokaew, S. Rayanakorn, A. Wu, D. B. C. Chaiyakunapruk, N.
Cost Effectiveness of Pneumococcal Vaccination in Children in Low- and Middle-Income Countries: A Systematic Review
Newborn Children Adolescents Low and Middle Income Countries Pneumococcal disease Economic aspects
Rating:
Not applicable
2016 ∙ Segal, N. Greenberg, D. Dagan, R. Ben-Shimol, S.
Disparities in PCV impact between different ethnic populations cohabiting in the same region: A systematic review of the literature
All age groups Pneumococcal disease Efficacy/effectiveness Ethical issues
Rating:
Critically low
2016 ∙ Gibson, E. Begum, N. Sigmundsson, B. Sackeyfio, A. Hackett, J. Rajaram, S.
Economic evaluation of pediatric influenza immunization program compared with other pediatric immunization programs: A systematic review
All age groups Influenza Rotavirus Meningococcal disease Pneumococcal disease Human papillomavirus (HPV) Hepatitis B Varicella Economic aspects
Rating:
Not applicable
2016 ∙ Remschmidt, C. Harder, T. Wichmann, O. Bogdan, C. Falkenhorst, G.
Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: A systematic review
Adults Older adults Pneumococcal disease Efficacy/effectiveness Safety
Rating:
High
Loading...